Catherine Stehman-breen - Net Worth and Insider Trading
Catherine Stehman-breen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Catherine Stehman-breen owns 4 companies in total, including Dyne Therapeutics Inc (DYN) , Generation Bio Co (GBIO) , and Sarepta Therapeutics Inc (SRPT) among others .
Click here to see the complete history of Catherine Stehman-breen’s form 4 insider trades.
Insider Ownership Summary of Catherine Stehman-breen
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DYN | Dyne Therapeutics Inc | 2020-09-16 | director |
GBIO | Generation Bio Co | 2020-06-11 | director |
SRPT | Sarepta Therapeutics Inc | 2017-04-03 | SVP & Chief Medical Officer |
2021-07-29 | director |
Catherine Stehman-breen Trading Performance
Catherine Stehman-breen Ownership Network
Ownership Network List of Catherine Stehman-breen
Ownership Network Relation of Catherine Stehman-breen
Catherine Stehman-breen Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Catherine Stehman-breen is the director of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include director & 10 percent owner Dirk Kersten , See Remarks Richard William Scalzo , and Chief Operating Officer Susanna Gatti High .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Catherine Stehman-breen made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 446,445 shares made by Dirk Kersten , a net sale of 327,516 shares made by Richard William Scalzo , and a net sale of 273,683 shares made by Susanna Gatti High .
In summary, during the past 3 months, insiders sold 1,954,064 shares of Dyne Therapeutics Inc (DYN) in total and bought 32,000 shares, with a net sale of 1,922,064 shares. During the past 18 months, 7,985,414 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 6,239,129 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Catherine Stehman-breen Mailing Address
Above is the net worth, insider trading, and ownership report for Catherine Stehman-breen. You might contact Catherine Stehman-breen via mailing address: 215 First Street, Suite 415, Cambridge Ma 02142.